SCHEMBL12406528

SCHEMBL12406528

O=C1S/C(=C\c2ccc(O)c(C(F)(F)F)c2)C(=O)N1Cc1cccc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 2/20 0.60
▸ PIM1 P11309 2/20 0.49
▸ NLRP3 Q96P20 1/20 0.46
▸ PTPN1 P18031 3/20 0.46
▸ ACP1 P24666 2/20 0.46
▸ S1PR1 P21453 1/20 0.46
▸ MEN1 O00255 2/20 0.45
▸ POLB P06746 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ CRHBP P24387 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ CRHR2 Q13324 1/20 0.45
▸ NOD2 Q9HC29 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ AKR1B1 P15121 1/20 0.44
▸ PPARG P37231 1/20 0.43
▸ ESRRA P11474 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2174422 1.00 SLC2A1 (0.60) SLC2A1PIM1NLRP3PTPN1ACP1
SCHEMBL2174424 1.00 SLC2A1 (0.60) SLC2A1PIM1NLRP3PTPN1ACP1
SCHEMBL1614720 0.89 SLC2A1 (0.65) SLC2A1PIM1NLRP3PTPN1ACP1
SCHEMBL2173288 0.85 PPARG (0.52) PIM1PTPN1ACP1MEN1POLB
SCHEMBL2173285 0.85 PPARG (0.52) PIM1PTPN1ACP1MEN1POLB
SCHEMBL2171659 0.84 SLC2A1 (0.66) SLC2A1PIM1NLRP3PTPN1ACP1
SCHEMBL1614982 0.84 SLC2A1 (0.66) SLC2A1PIM1NLRP3PTPN1ACP1
SCHEMBL2171655 0.84 SLC2A1 (0.66) SLC2A1PIM1NLRP3PTPN1ACP1
SCHEMBL12712433 0.80 SLC2A1 (0.56) SLC2A1PIM1NLRP3PTPN1ACP1
SCHEMBL2172182 0.79 SLC2A1 (0.78) SLC2A1S1PR1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2254576-B1 ANDROGEN RECEPTOR-ABLATIVE AGENTS UNIV OHIO STATE RES FOUND (US) 2013-08-28 — — EP disclosed
US-7973062-B2 Androgen receptor-ablative agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-07-05 — — US disclosed
US-7973062-B2 Androgen receptor-ablative agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-07-05 — — US disclosed
US-20090291992-A1 ANDROGEN RECEPTOR-ABLATIVE AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2009-11-26 — — US disclosed
US-20090291992-A1 ANDROGEN RECEPTOR-ABLATIVE AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2009-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291992-A1 ANDROGEN RECEPTOR-ABLATIVE AGENTS AR, ESRRB, KLK3 SLC2A1 2158/4885PIM1 4023/4885NLRP3 4366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback